• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

正常对照者中的胆固醇与认知表现,以及在转换为轻度认知障碍后选择性使用他汀类药物的影响:临床试验队列的结果。

Cholesterol and cognitive performance in normal controls and the influence of elective statin use after conversion to mild cognitive impairment: results in a clinical trial cohort.

机构信息

Roberts Laboratory for Neurodegenerative Disease Research, Sun Health Research Institute, Sun City, Ariz., USA.

出版信息

Neurodegener Dis. 2010;7(1-3):183-6. doi: 10.1159/000295660. Epub 2010 Mar 12.

DOI:10.1159/000295660
PMID:20224282
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2859238/
Abstract

BACKGROUND

We reported a significant 67% reduction in the hazard risk of incident Alzheimer's disease (AD) with elective statin use in the AD Anti-inflammatory Prevention Trial (ADAPT), without a reduction in risk of incident mild cognitive impairment (MCI).

OBJECTIVE

To assess if cholesterol levels are associated with cognitive performance and determine if statin use alters cognitive performance after onset of MCI.

DESIGN

Fractionated cholesterol levels, neurological and cognitive status were evaluated annually. Comparisons of non-LLA (lipid-lowering agent) users or statin-LLA users were performed blind to the ADAPT medication randomization. Pearson's correlations were validated using a time-dependent linear mixed model.

RESULTS

The MMSE performance significantly declined over time in non-LLA users, and, after adjusting for this, a significant positive correlation between MMSE and HDL was identified (p = 0.0002). A negative correlation between total and LDL cholesterol, and immediate and delayed recall of the Rivermead paragraph was significant (total cholesterol, p < 0.003; LDL, p < 0.02). Pilot data suggest a positive signal on delayed recall of both the Hopkins word list and Rivermead paragraph with deterioration in the non-LLA users and improvement in the statin users after conversion to MCI.

CONCLUSION

Cholesterol levels may be associated with differential performance on the MMSE and measures of learning or memory. The trend for improved delayed recall in statin users with MCI compared to non-LLA users with MCI may have contributed to the reduced hazards risk of incident AD without reducing the risk of MCI.

摘要

背景

我们报告称,在 AD 抗炎预防试验(ADAPT)中,选择性使用他汀类药物可显著降低阿尔茨海默病(AD)发病的风险,降低 67%,而不会降低轻度认知障碍(MCI)发病的风险。

目的

评估胆固醇水平是否与认知表现相关,并确定他汀类药物是否会改变 MCI 发病后的认知表现。

设计

每年评估分段胆固醇水平、神经和认知状态。非 LLA(降脂药)使用者或他汀类药物使用者与 ADAPT 药物随机分组进行比较。采用时间依赖性线性混合模型验证 Pearson 相关性。

结果

非 LLA 使用者的 MMSE 表现随时间显著下降,调整后发现 MMSE 与高密度脂蛋白(HDL)呈显著正相关(p = 0.0002)。总胆固醇和 LDL 胆固醇与即时和延迟回忆 Rivermead 段落之间存在显著负相关(总胆固醇,p < 0.003;LDL,p < 0.02)。初步数据表明,在非 LLA 使用者中,Hopkins 单词列表和 Rivermead 段落的延迟回忆出现恶化,他汀类药物使用者的延迟回忆有所改善,这一信号呈阳性。

结论

胆固醇水平可能与 MMSE 以及学习或记忆的测量结果相关。与非 LLA 使用者相比,他汀类药物使用者在 MCI 中的延迟回忆改善的趋势可能导致 AD 发病的风险降低,而不会降低 MCI 的风险。

相似文献

1
Cholesterol and cognitive performance in normal controls and the influence of elective statin use after conversion to mild cognitive impairment: results in a clinical trial cohort.正常对照者中的胆固醇与认知表现,以及在转换为轻度认知障碍后选择性使用他汀类药物的影响:临床试验队列的结果。
Neurodegener Dis. 2010;7(1-3):183-6. doi: 10.1159/000295660. Epub 2010 Mar 12.
2
Reduced risk of incident AD with elective statin use in a clinical trial cohort.在一项临床试验队列中,选择性使用他汀类药物可降低患阿尔茨海默病(AD)的风险。
Curr Alzheimer Res. 2008 Aug;5(4):416-21. doi: 10.2174/156720508785132316.
3
Statins and cognitive decline in patients with Alzheimer's and mixed dementia: a longitudinal registry-based cohort study.他汀类药物与阿尔茨海默病和混合性痴呆患者认知能力下降的关系:一项基于纵向登记的队列研究。
Alzheimers Res Ther. 2023 Dec 20;15(1):220. doi: 10.1186/s13195-023-01360-0.
4
Statin use and hippocampal volumes in elderly subjects at risk for Alzheimer's disease: a pilot observational study.他汀类药物的使用与有患阿尔茨海默病风险的老年受试者海马体积:一项初步观察性研究。
Am J Alzheimers Dis Other Demen. 2004 Sep-Oct;19(5):275-8. doi: 10.1177/153331750401900506.
5
Serum lipoprotein levels, statin use, and cognitive function in older women.老年女性的血清脂蛋白水平、他汀类药物使用情况与认知功能
Arch Neurol. 2002 Mar;59(3):378-84. doi: 10.1001/archneur.59.3.378.
6
Cholesterol, copper and Abeta in controls, MCI, AD and the AD cholesterol-lowering treatment trial (ADCLT).对照组、轻度认知障碍(MCI)、阿尔茨海默病(AD)及AD降胆固醇治疗试验(ADCLT)中的胆固醇、铜和β淀粉样蛋白
Curr Alzheimer Res. 2005 Dec;2(5):527-39. doi: 10.2174/156720505774932296.
7
Circulating cholesterol levels, apolipoprotein E genotype and dementia severity influence the benefit of atorvastatin treatment in Alzheimer's disease: results of the Alzheimer's Disease Cholesterol-Lowering Treatment (ADCLT) trial.循环胆固醇水平、载脂蛋白E基因型和痴呆严重程度影响阿托伐他汀治疗阿尔茨海默病的疗效:阿尔茨海默病降胆固醇治疗(ADCLT)试验结果
Acta Neurol Scand Suppl. 2006;185:3-7. doi: 10.1111/j.1600-0404.2006.00690.x.
8
Statins, risk of dementia, and cognitive function: secondary analysis of the ginkgo evaluation of memory study.他汀类药物、痴呆风险和认知功能:银杏叶评估记忆研究的二次分析。
J Stroke Cerebrovasc Dis. 2012 Aug;21(6):436-44. doi: 10.1016/j.jstrokecerebrovasdis.2010.11.002. Epub 2011 Jan 14.
9
Effects of LDL Cholesterol and Statin Use on Verbal Learning and Memory in Older Adults at Genetic Risk for Alzheimer's Disease.载脂蛋白 E 基因多态性与阿尔茨海默病风险及他汀类药物对血脂水平的影响 他汀类药物治疗对阿尔茨海默病高危老年人语言学习和记忆的影响
J Alzheimers Dis. 2020;75(3):903-910. doi: 10.3233/JAD-191090.
10
Statin Use and Risk of Cognitive Decline in the ADNI Cohort.他汀类药物的使用与 ADNI 队列认知能力下降的风险。
Am J Geriatr Psychiatry. 2020 May;28(5):507-517. doi: 10.1016/j.jagp.2019.11.003. Epub 2019 Nov 11.

引用本文的文献

1
Dyslipidemia and cerebral atrophy among health check-up individuals: A cross-sectional study.健康体检人群中的血脂异常与脑萎缩:一项横断面研究。
Int J Cardiol Cardiovasc Risk Prev. 2025 Mar 8;25:200394. doi: 10.1016/j.ijcrp.2025.200394. eCollection 2025 Jun.
2
Anatomical Brain Changes and Cognitive Abilities in Patients with Obstructive Sleep Apnea Syndrome and Nonalcoholic Fatty Liver Disease.阻塞性睡眠呼吸暂停综合征和非酒精性脂肪性肝病患者的大脑解剖结构变化与认知能力。
Can J Gastroenterol Hepatol. 2021 Oct 20;2021:8873652. doi: 10.1155/2021/8873652. eCollection 2021.
3
Development and validation of a clinical model (DREAM-LDL) for post-stroke cognitive impairment at 6 months.开发并验证一种用于卒中后 6 个月认知障碍的临床模型(DREAM-LDL)。
Aging (Albany NY). 2021 Sep 10;13(17):21628-21641. doi: 10.18632/aging.203507.
4
Mendelian Randomization of Dyslipidemia on Cognitive Impairment Among Older Americans.美国老年人血脂异常与认知障碍的孟德尔随机化研究
Front Neurol. 2021 Jun 23;12:660212. doi: 10.3389/fneur.2021.660212. eCollection 2021.
5
Low Cholesterol Level Linked to Reduced Semantic Fluency Performance and Reduced Gray Matter Volume in the Medial Temporal Lobe.低胆固醇水平与语义流畅性表现降低及内侧颞叶灰质体积减少有关。
Front Aging Neurosci. 2020 Mar 31;12:57. doi: 10.3389/fnagi.2020.00057. eCollection 2020.
6
The efficacy of statins in the treatment of Alzheimer's disease: a meta-analysis of randomized controlled trial.他汀类药物治疗阿尔茨海默病的疗效:一项随机对照试验的荟萃分析。
Neurol Sci. 2020 Jun;41(6):1391-1404. doi: 10.1007/s10072-020-04243-6. Epub 2020 Jan 13.
7
Depression and the Diagnosis of MCI in a Culturally Diverse Sample in the United States.在美国的文化多元样本中,抑郁与轻度认知障碍的诊断。
Arch Clin Neuropsychol. 2021 Feb 12;36(2):214-230. doi: 10.1093/arclin/acz043.
8
Does taking statins affect the pathological burden in autopsy-confirmed Alzheimer's dementia?服用他汀类药物是否会影响尸检证实的阿尔茨海默病痴呆的病理负担?
Alzheimers Res Ther. 2018 Oct 2;10(1):104. doi: 10.1186/s13195-018-0430-7.
9
The Effect of Statins on Rate of Cognitive Decline in Mild Cognitive Impairment.他汀类药物对轻度认知障碍患者认知衰退速率的影响。
Alzheimers Dement (N Y). 2017 Jun;3(2):149-156. doi: 10.1016/j.trci.2017.01.001.
10
Elevated levels of serum cholesterol are associated with better performance on tasks of episodic memory.血清胆固醇水平升高与情景记忆任务表现较好有关。
Metab Brain Dis. 2016 Apr;31(2):465-73. doi: 10.1007/s11011-016-9797-y. Epub 2016 Feb 12.

本文引用的文献

1
Statins are associated with a reduced risk of Alzheimer disease regardless of lipophilicity. The Rotterdam Study.无论亲脂性如何,他汀类药物都与阿尔茨海默病风险降低相关。鹿特丹研究。
J Neurol Neurosurg Psychiatry. 2009 Jan;80(1):13-7. doi: 10.1136/jnnp.2008.150433. Epub 2008 Oct 17.
2
Reduced risk of incident AD with elective statin use in a clinical trial cohort.在一项临床试验队列中,选择性使用他汀类药物可降低患阿尔茨海默病(AD)的风险。
Curr Alzheimer Res. 2008 Aug;5(4):416-21. doi: 10.2174/156720508785132316.
3
Use of statins and incidence of dementia and cognitive impairment without dementia in a cohort study.一项队列研究中他汀类药物的使用与痴呆症及无痴呆的认知障碍发病率
Neurology. 2008 Jul 29;71(5):344-50. doi: 10.1212/01.wnl.0000319647.15752.7b.
4
Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial.在一项随机对照试验的早期结果中,萘普生和塞来昔布不能预防阿尔茨海默病。
Neurology. 2007 May 22;68(21):1800-8. doi: 10.1212/01.wnl.0000260269.93245.d2. Epub 2007 Apr 25.
5
Cardiovascular and cerebrovascular events in the randomized, controlled Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT).随机对照的阿尔茨海默病抗炎预防试验(ADAPT)中的心血管和脑血管事件
PLoS Clin Trials. 2006 Nov 17;1(7):e33. doi: 10.1371/journal.pctr.0010033.
6
Conversion to dementia from mild cognitive disorder: the Cache County Study.从轻度认知障碍转变为痴呆症:卡什县研究
Neurology. 2006 Jul 25;67(2):229-34. doi: 10.1212/01.wnl.0000224748.48011.84.
7
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial.普伐他汀用于有血管疾病风险的老年人(PROSPER):一项随机对照试验。
Lancet. 2002 Nov 23;360(9346):1623-30. doi: 10.1016/s0140-6736(02)11600-x.
8
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.辛伐他汀降低胆固醇对20536例高危个体的MRC/BHF心脏保护研究:一项随机安慰剂对照试验。
Lancet. 2002 Jul 6;360(9326):7-22. doi: 10.1016/S0140-6736(02)09327-3.